Lantheus Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
LNTH$101.62+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Operating activities | |||
| Net income | $312,442 | $326,661 | $28,067 |
| Adjustments to reconcile net income to net cash flows from operating activities: | |||
| Depreciation, amortization and accretion | 64,624 | 60,043 | 47,929 |
| Impairment of long-lived assets | — | 138,050 | — |
| Asset retirement obligation acceleration | — | — | 280 |
| Gain on interest rate swap termination | — | — | (5,494) |
| Amortization of debt related costs | 4,296 | 4,300 | 1,249 |
| Changes in fair value of contingent assets and liabilities | (2,699) | (9,275) | 34,700 |
| Charges incurred in connection with acquired IPR&D | 66,000 | — | 260,000 |
| Loss on extinguishment of debt | — | — | 588 |
| Provision for excess and obsolete inventory | (904) | 7,914 | 7,145 |
| Stock-based compensation | 76,393 | 50,507 | 29,262 |
| Gain on disposal of assets | (8,415) | — | — |
| Gain on sale of RELISTOR licensed intangible asset associated with net sales royalties | — | (51,789) | — |
| Unrealized loss on investment in equity securities | 43,564 | — | — |
| Deferred taxes | (30,029) | (55,632) | (48,016) |
| Long-term indemnification receivable | — | 3,929 | 9,554 |
| Long-term income tax payable and other long-term liabilities | 5,236 | (3,103) | (12,477) |
| Other | 12,194 | 4,855 | 4,059 |
| Changes in assets and liabilities which provided (used) cash: | |||
| Accounts receivable | (37,685) | (68,637) | (128,460) |
| Inventory | (2,670) | (36,220) | (7,508) |
| Other current assets | 4,440 | (2,418) | (2,440) |
| Other long-term assets | — | — | (533) |
| Accounts payable | (8,804) | 17,189 | 301 |
| Accrued expenses and other liabilities | 46,767 | (81,114) | 63,575 |
| Net cash provided by operating activities | 544,750 | 305,260 | 281,781 |
| Investing activities | |||
| Capital expenditures | (51,625) | (46,555) | (18,347) |
| Proceeds from sale of assets, net | 17,767 | 97,839 | 1,800 |
| Purchases of investment in equity securities | (83,246) | — | — |
| Acquisition of assets, net | (80,911) | (45,345) | (260,000) |
| Acquisition of exclusive license option | (28,000) | — | — |
| Net cash (used in) provided by investing activities | (226,015) | 5,939 | (276,547) |
| Financing activities | |||
| Proceeds from issuance of common stock | 3,450 | 1,933 | 1,375 |
| Debt issuance costs | — | — | (95) |
| Proceeds from issuance of long-term debt, net | — | — | 557,750 |
| Contingent value rights settlement | — | (3,700) | — |
| Payments on long-term debt and other borrowings | (318) | (717) | (175,385) |
| Deferred financing costs | (2,331) | — | (2,315) |
| Proceeds from interest rate swap termination | — | — | 5,583 |
| Proceeds from stock option exercises | 3,278 | 3,816 | 7,537 |
| Payments for minimum statutory tax withholding related to net share settlement of equity awards | (22,615) | (14,394) | (7,759) |
| Repurchase of common stock | (100,000) | — | (75,000) |
| Net cash (used in) provided by financing activities | (118,536) | (13,062) | 311,691 |
| Effect of foreign exchange rates on cash and cash equivalents | (998) | (93) | (335) |
| Net increase in cash and cash equivalents and restricted cash | 199,201 | 298,044 | 316,590 |
| Cash and cash equivalents and restricted cash, beginning of year | 715,285 | 417,241 | 100,651 |
| Cash and cash equivalents and restricted cash, end of year | $914,486 | $715,285 | $417,241 |
Consolidated Statements of Cash Flows (Continued)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Reconciliation to amounts within the consolidated balance sheets | |||
| Cash and cash equivalents | $912,814 | $713,656 | $415,652 |
| Restricted cash included in other long-term assets | 1,672 | 1,629 | 1,589 |
| Cash, cash equivalents and restricted cash at end of period | $914,486 | $715,285 | $417,241 |
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Supplemental disclosure of cash flow information | |||
| Cash paid during the period for: | |||
| Interest | $15,094 | $15,387 | $5,064 |
| Income taxes, net of refunds of $2,688, $25 and $50, respectively | $153,815 | $151,579 | $54,049 |
| Schedule of non-cash investing and financing activities | |||
| Additions of property, plant and equipment included in liabilities | $5,058 | $6,978 | $2,370 |
| Lease liability settled through transfer of lease | $762 | $— | $— |
| Right-of-use asset obtained in exchange for operating lease liabilities | $63 | $29,396 | $11,019 |
| Excise tax payable on net common stock repurchases | $251 | $— | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.